Form 4: Revolution Medicines Executive Sells Shares
Insider Transaction (Form 4)
Jeff Cislini, SVP & General Counsel of Revolution Medicines, Inc., sold 3,366 shares of common stock on September 16, 2026.
Summary
- Open-market sale: disposed of 52 Common Stock at $195.01 ($10,140) on September 16, 2026; holds 55,855 after (Direct).
- Open-market sale: disposed of 3,314 Common Stock at $199.30 ($660,491) on September 16, 2026; holds 52,541 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $670,631 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeff Cislini — Officer (SVP & General Counsel)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 52 | $195 | $10.1K | 55,855 |
| 2026-09-16 | Open-market sale | Common Stock | 3,314 | $199 | $660.5K | 52,541 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (52 shares) |
| 2026-09-16 | Open-market sale (3,314 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Jeff Cislini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.